Methods and compositions for treating tumor diseases

Details for Australian Patent Application No. 2008223541 (hide)

Owner Amgen Inc.

Inventors Calzone, Frank J.; Haqq, Christopher; Tolcher, Anthony W.; Beltran, Pedro J.; Friberg, Gregory

Agent Freehills

Pub. Number AU-B-2008223541

PCT Pub. Number WO2008/108986

Priority 60/904,538 02.03.07 US

Filing date 29 February 2008

Wipo publication date 12 September 2008

Acceptance publication date 5 April 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/108986 Priority application(s): WO2008/108986

5 April 2012 Application Accepted

  Published as AU-B-2008223541

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223544-Cultures with improved phage resistance

2008223528-Liquid sulfonylurea herbicide formulations